Comparative proteomics analysis of sodium selenite-induced apoptosis in human prostate cancer cells

Metallomics

Volumn 5, Issue 5, 2013, Pages 541-550

  Chen, Ping ^a   Wang, Lixiang ^b   Li, Na ^a   Liu, Qiong ^b   Ni, Jiazuan ^a  

^a SHENZHEN UNIVERSITY   (China)

^b Shenzhen Key Laboratory of Marine Biotechnology and Ecology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-APOPTOTIC PROTEIN; COMPARATIVE PROTEOMICS; HUMAN PROSTATE CANCER; HUMAN PROSTATE CANCER CELLS; MALDI-TOF MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PATHWAYS; WESTERN-BLOT ANALYSIS;

CELL DEATH; DISEASES; FLOW CYTOMETRY; MASS SPECTROMETRY; MITOCHONDRIA; MOLECULAR BIOLOGY; SELENIUM; SODIUM;

PROTEINS;

CASPASE 8; COPPER ZINC SUPEROXIDE DISMUTASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN ERP29; REACTIVE OXYGEN METABOLITE; SODIUM SELENITE; STATHMIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL COMMUNICATION; CELL METABOLISM; CELL STRUCTURE; CELL VIABILITY; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; FLOW CYTOMETRY; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; CELL SURVIVAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; PROTEOMICS; REACTIVE OXYGEN SPECIES; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SODIUM SELENITE;

EID: 84877252601     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c3mt00002h     Document Type: Conference Paper

References (43)

1. S. J. Fairweather-Tait Y. Bao M. R. Broadley R. Collings D. Ford J. E. Hesketh R. Hurst Selenium in human health and disease Antioxid. Redox Signaling 2011 14 1337 1383
2. J. Bleys A. Navas-Acien E. Guallar Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults Arch. Intern. Med. 2008 168 404 410
3. A. J. Duffield-Lillico E. H. Slate M. E. Reid B. W. Turnbull P. A. Wilkins G. F. Combs, Jr H. K. Park E. G. Gross G. F. Graham M. S. Stratton J. R. Marshall L. C. Clark Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial J. Natl. Cancer Inst. 2003 95 1477 1481
4. G. F. Combs, Jr Status of selenium in prostate cancer prevention Br. J. Cancer 2004 91 195 199
5. Y. C. Chen D. M. Sosnoski U. H. Gandhi L. J. Novinger K. S. Prabhu A. M. Mastro Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer Carcinogenesis 2009 30 1941 1948
6. H. Fritz D. Kennedy D. Fergusson R. Fernandes K. Cooley A. Seely S. Sagar R. Wong D. Seely Selenium and lung cancer: a systematic review and meta analysis PLoS One 2011 6 e26259
7. J. S. Park J. Y. Ryu H. K. Jeon Y. J. Cho Y. A. Park J. J. Choi J. W. Lee B. G. Kim D. S. Bae The effects of selenium on tumor growth in epithelial ovarian carcinoma J. Gynecol. Oncol. 2012 23 190 196
8. L. C. Clark The epidemiology of selenium and cancer Fed. Proc. 1985 44 2584 2589
9. R. Hurst L. Hooper T. Norat R. Lau D. Aune D. C. Greenwood R. Vieira R. Collings L. J. Harvey J. A. Sterne R. Beynon J. Savovic S. J. Fairweather-Tait Selenium and prostate cancer: systematic review and meta-analysis Am. J. Clin. Nutr. 2012 96 111 122
10. P. D. Whanger Selenium and its relationship to cancer: an update Br. J. Nutr. 2004 91 11 28
11. H. E. Ganther Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase Carcinogenesis 1999 20 1657 1666
12. G. F. Combs, Jr W. P. Gray Chemopreventive agents: selenium Pharmacol. Ther. 1998 79 179 192
13. L. V. Papp J. Lu A. Holmgren K. K. Khanna From selenium to selenoproteins: synthesis, identity, and their role in human health Antioxid. Redox Signaling 2007 9 775 806
14. N. M. Corcoran M. Najdovska A. J. Costello Inorganic selenium retards progression of experimental hormone refractory prostate cancer J. Urol. 2004 171 907 910
15. R. S. Bhattacharyya B. Husbeck D. Feldman S. J. Knox Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer Int. J. Radiat. Oncol., Biol., Phys. 2008 72 935 940
16. H. Wang D. T. Kwok W. Wang Z. Wu L. Tong Y. Zhang P. K. Chu Osteoblast behavior on polytetrafluoroethylene modified by long pulse, high frequency oxygen plasma immersion ion implantation Biomaterials 2010 31 413 419
17. C. C. Liang A. Y. Park J. L. Guan In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro Nat. Protocols 2007 2 329 333
18. D. G. Menter A. L. Sabichi S. M. Lippman Selenium effects on prostate cell growth Cancer Epidemiol., Biomarkers Prev. 2000 9 1171 1182
19. G. Munkacsy R. Abdul-Ghani Z. Mihaly B. Tegze O. Tchernitsa P. Surowiak R. Schafer B. Gyorffy PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer Br. J. Cancer 2010 102 361 368
20. J. Lee S. S. Kim Current implications of cyclophilins in human cancers J. Exp. Clin. Cancer Res. 2010 29 97
21. D. E. Christofferson J. Yuan Cyclophilin A release as a biomarker of necrotic cell death Cell Death Differ. 2010 17 1942 1943
22. B. A. Howard Z. Zheng M. J. Campa M. Z. Wang A. Sharma E. Haura J. E. Herndon, 2nd M. C. Fitzgerald G. Bepler E. F. Patz, Jr Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer Lung Cancer 2004 46 313 323
23. D. Gao I. F. Bambang T. C. Putti Y. K. Lee D. R. Richardson D. Zhang ERp29 induces breast cancer cell growth arrest and survival through modulation of activation of p38 and up-regulation of ER stress protein p58IPK Lab. Invest. 2012 92 200 213
24. C. M. Clements R. S. McNally B. J. Conti T. W. Mak J. P. Ting DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 Proc. Natl. Acad. Sci. U. S. A. 2006 103 15091 15096
25. H. F. Yuen Y. P. Chan S. Law G. Srivastava M. El-Tanani T. W. Mak K. W. Chan DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma Cancer Epidemiol., Biomarkers Prev. 2008 17 3593 3602
26. H. Arnouk M. A. Merkley R. H. Podolsky H. Stoppler C. Santos M. Alvarez J. Mariategui D. Ferris J. R. Lee W. S. Dynan Characterization of Molecular Markers Indicative of Cervical Cancer Progression Proteomics: Clin. Appl. 2009 3 516 527
27. Y. Chen M. Kang W. Lu Q. Guo B. Zhang Q. Xie Y. Wu DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer J. Cancer Res. Clin. Oncol. 2012 138 1463 1474
28. C. E. Estrada-Carrasco J. E. Flores-Terrazas E. Floriano-Sánchez M. Castro-Marín J. L. López-Silvestre J. G. Campos-Salcedo M. A. Zapata-Villalba L. A. Mendoza-Álvarez N. Cárdenas-Rodríguez Regulation of antioxidant enzymes as prostate tumor markers Rev. Mex. Urol. 2010 70 157 163
29. Z. A. Wood E. Schroder J. R. Harris L. B. Poole Structure, mechanism and regulation of peroxiredoxins Trends Biochem. Sci. 2003 28 32 40
30. S. G. Rhee H. Z. Chae K. Kim Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radical Biol. Med. 2005 38 1543 1552
31. D. Nagakubo T. Taira H. Kitaura M. Ikeda K. Tamai S. M. Iguchi-Ariga H. Ariga DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with Ras Biochem. Biophys. Res. Commun. 1997 231 509 513
32. Y. Hod Differential control of apoptosis by DJ-1 in prostate benign and cancer cells J. Cell. Biochem. 2004 92 1221 1233
33. J. P. MacKeigan C. M. Clements J. D. Lich R. M. Pope Y. Hod J. P. Ting Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha Cancer Res. 2003 63 6928 6934
34. L. Fu Q. Liu L. Shen Y. Wang Proteomic study on sodium selenite-induced apoptosis of human cervical cancer HeLa cells J. Trace Elem. Med. Biol. 2011 25 130 137
35. L. Bubendorf M. Kolmer J. Kononen P. Koivisto S. Mousses Y. Chen E. Mahlamaki P. Schraml H. Moch N. Willi A. G. Elkahloun T. G. Pretlow T. C. Gasser M. J. Mihatsch G. Sauter O. P. Kallioniemi Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays J. Natl. Cancer Inst. 1999 91 1758 1764
36. J. Li B. Lee A. S. Lee Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53 J. Biol. Chem. 2006 281 7260 7270
37. K. Mori Tripartite management of unfolded proteins in the endoplasmic reticulum Cell 2000 101 451 454
38. M. B. Sporn The war on cancer Lancet 1996 347 1377 1381
39. G. L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 2003 3 721 732
40. K. S. Kimbro J. W. Simons Hypoxia-inducible factor-1 in human breast and prostate cancer Endocr.-Relat. Cancer 2006 13 739 749
41. X. He Z. Zheng J. Li Q. Ben J. Liu J. Zhang J. Ji B. Yu X. Chen L. Su L. Zhou B. Liu Y. Yuan DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA Carcinogenesis 2012 33 555 562
42. S. Neng-Yao L. Ko-Jiunn The Role of Enolase in Tissue Invasion and Metastasis of Pathogens and Tumor Cells J. Cancer Mol. 2007 3 45 48
43. S. Al-Salam N. Balalaa I. Faour S. Akhter M. Alashari HIF-1alpha, VEGF and WT-1 are protagonists in bilateral primary angiosarcoma of breast: a case report and review of literature Int. J. Clin. Exp. Pathol. 2012 5 247 253